The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses

Date: October 1, 2010
Pages: 275
Price:
US$ 1,480.00
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L9EB0A95767EN
Leaflet:

Download PDF Leaflet

The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
Global PDF: US$ 3,900.00

For each company, the analyses present:
  • Extensive review of major ethical, OTC, and generic drugs.
  • Most recent new drug introductions and indications.
The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 275 pages

Ask Your Question

The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: